Izzet Dogan (İzzet Doğan)

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 16

Top Topics

Small Cell Lung Cancer

Prognostic Factors

Basal Cell Carcinoma

Ejection Fraction

Top Venues

European journal of breast health

Journal of chemotherapy (Florence, Italy)

Indian journal of surgical oncology

This page only lists publications with an associated author ORCID identifier.

Publications

Izzet Dogan, Melin Aydan Ahmed, Anıl Yıldız, Sezai Vatansever
Rechallenge of Trastuzumab-based Therapy in HER2-Positive Breast Cancer Patients who Progressed Under TDM-1. Indian journal of surgical oncology 15 (3) (2024)
Izzet Dogan, Anıl Yıldız, Melin Aydan Ahmed, Sezai Vatansever
Efficacy of Lapatinib Plus Capecitabine After TDM-1 in HER2-Positive Metastatic Breast Cancer Patients. Indian journal of surgical oncology 15 (3) (2024)
Izzet Dogan, Sercan Aksoy, Burcu Cakar, Gul Basaran, Ozlem Ercelep, Nil Molinas Mandel, Taner Korkmaz, Erhan Gokmen, Cem Sener, Adnan Aydiner, Pinar Saip, Yesim Eralp
Demographic and Clinical Features of Patients with Metastatic Breast Cancer: A Retrospective Multicenter Registry Study of the Turkish Oncology Group. Cancers 15 (6) (2023)
Izzet Dogan, Sercan Aksoy, Burcu Cakar, Gul Basaran, Ozlem Ercelep, Nil Molinas Mandel, Taner Korkmaz, Erhan Gokmen, Cem Sener, Adnan Aydiner, Pinar Saip, Yesim Eralp
Demographic and Clinical Features of Patients with Metastatic Breast Cancer: A Retrospective Multicenter Registry Study of the Turkish Oncology Group. Cancers 15 (6) (2023)
Naziye Ak, Zeynep Tuz, Esra Aydin, Ferhat Ferhatoglu, Murat Sarı, Nail Paksoy, Izzet Dogan, Anıl Yıldız, Rian Dişçi, Pınar Mualla Saip
The effect of parity, breastfeeding history, and duration on clinical and pathological characteristics of breast cancer patients. Turkish journal of medical sciences 54 (1) (2023)
Izzet Dogan, Nail Paksoy, Sezai Vatansever, Adnan Aydıner
Prognostic Factors Influencing Progression-Free Survival in HER2-Positive Metastatic Breast Cancer Patients Who Were Treated With A Combination of Lapatinib and Capecitabine. European journal of breast health 19 (2) (2023)
Izzet Dogan, Esra Aydin, Ni Jat Khanmammadov, Nail Paksoy, Pınar Mualla Saip, Adnan Aydıner
Termination of trastuzumab in HER2-positive metastatic breast cancer patients who received trastuzumab beyond progression. Scientific reports 13 (1) (2023)
Naziye Ak, Zeynep Tuz, Esra Aydin, Ferhat Ferhatoglu, Murat Sarı, Nail Paksoy, Izzet Dogan, Anıl Yıldız, Rian Dişçi, Pınar Mualla Saip
The effect of parity, breastfeeding history, and duration on clinical and pathological characteristics of breast cancer patients. Turkish journal of medical sciences 54 (1) (2023)
Seval Ay, Muhammet Mustafa Atcı, Rukiye Arıkan, Ozgecan Dulgar, Deniz Tataroğlu Özyükseler, Nail Paksoy, Izzet Dogan, Buğra Öztosun, Didem Taştekin, Bala Başak Öven, Mahmut Gümüş
FOLFIRINOX versus gemcitabine plus nab-paclitaxel as the first-line chemotherapy in metastatic pancreatic cancer. Journal of chemotherapy (Florence, Italy) 34 (7) (2022)
Izzet Dogan, Esra Aydin, Samet Topuz, Pinar Saip, Mehmet Y Salihoglu, Adnan Aydiner
Hormonal Therapy in Pretreated Patients With Recurrent Ovary Granulosa Cell Tumor. Journal of pharmacy practice (2022)
Izzet Dogan, Ayca Iribas, Melin Aydan Ahmed, Mert Başaran
Efficacy of the VIT (vincristine, irinotecan and temozolomide) regimen in adults with metastatic Ewing sarcoma. Journal of chemotherapy (Florence, Italy) (2022)
Izzet Dogan, Esra Aydın, Yazıcı Hülya, Pınar Mualla Saip
Comparison of Clinical, Pathological, and Prognostic Features in BRCA Mutant and Wild-Type Male Breast Cancer Patients. European journal of breast health 18 (4) (2022)
Izzet Dogan, Mustafa Gurbuz, Nail Paksoy, Ferhat Ferhatoglu, Sezai Vatansever, Pinar Saip, Ahmet Demirkazik, Adnan Aydiner
Evaluation of clinicopathological features determining treatment response in patients with ALK mutant NSCLC. Medicine 101 (34) (2022)
Izzet Dogan, Didem Taştekin, Senem Karabulut, Burak Sakar
Capecitabine and temozolomide (CAPTEM) is effective in metastatic well-differentiated gastrointestinal neuroendocrine tumors. Journal of digestive diseases 23 (8-9) (2022)
Mustafa Gürbüz, Izzet Dogan, Erman Akkuş, Hande Ermiş, Güngör Utkan, Sezai Vatansever, Faruk Tas
Efficacy and tolerability of vismodegib treatment in locally advanced and metastatic basal cell carcinoma: Retrospective real-life data. Dermatologic therapy 34 (6) (2021)
Inci Kizildag Yirgin, Şükrü Mehmet Ertürk, Izzet Dogan, Sezai Vatansever
Are radiologists ready to evaluate true response to immunotherapy? Insights into imaging 12 (1) (2021)